The stock of Syra Health Corp (NASDAQ: SYRA) has increased by 5.68 when compared to last closing price of 0.39.Despite this, the company has seen a gain of 0.12% in its stock price over the last five trading days. prnewswire.com reported 2025-02-13 that CARMEL, Ind., Feb. 13, 2025 /PRNewswire/ — Syra Health Corp. (Nasdaq: SYRA), a healthcare technology company powering better health by providing meaningful solutions, announced today that it has been awarded a six-month, $135,000 contract with a Midwest-based university to develop prevention-focused virtual training modules in behavioral health.
Is It Worth Investing in Syra Health Corp (NASDAQ: SYRA) Right Now?
The 36-month beta value for SYRA is at 4.28. Analysts have varying views on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for SYRA is 7.44M, and currently, shorts hold a 6.23% of that float. The average trading volume for SYRA on February 13, 2025 was 1.74M shares.
SYRA’s Market Performance
SYRA’s stock has seen a 0.12% increase for the week, with a -15.56% drop in the past month and a 4.32% gain in the past quarter. The volatility ratio for the week is 10.51%, and the volatility levels for the past 30 days are at 13.60% for Syra Health Corp The simple moving average for the past 20 days is -10.09% for SYRA’s stock, with a -51.03% simple moving average for the past 200 days.
SYRA Trading at -7.72% from the 50-Day Moving Average
After a stumble in the market that brought SYRA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -87.35% of loss for the given period.
Volatility was left at 13.60%, however, over the last 30 days, the volatility rate increased by 10.51%, as shares sank -17.52% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -7.20% lower at present.
During the last 5 trading sessions, SYRA fell by -1.50%, which changed the moving average for the period of 200-days by -61.84% in comparison to the 20-day moving average, which settled at $0.4612. In addition, Syra Health Corp saw 0.75% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at SYRA starting from Prasad Priya, who purchase 5,303 shares at the price of $0.38 back on Sep 12 ’24. After this action, Prasad Priya now owns 10,295 shares of Syra Health Corp, valued at $2,015 using the latest closing price.
Stock Fundamentals for SYRA
Current profitability levels for the company are sitting at:
- -0.55 for the present operating margin
- 0.12 for the gross margin
The net margin for Syra Health Corp stands at -0.55. The total capital return value is set at -1.2. Equity return is now at value -404.51, with -120.88 for asset returns.
Based on Syra Health Corp (SYRA), the company’s capital structure generated 0.15 points at debt to capital in total, while cash flow to debt ratio is standing at -7.91. The debt to equity ratio resting at 0.17. The interest coverage ratio of the stock is -220.07.
Currently, EBITDA for the company is -2.84 million with net debt to EBITDA at 0.51. When we switch over and look at the enterprise to sales, we see a ratio of 0.36. The receivables turnover for the company is 8.09for trailing twelve months and the total asset turnover is 1.75. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.63.
Conclusion
In conclusion, Syra Health Corp (SYRA) has had a mixed performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
